Scale-Up and Post-Approval Changes (SUPACs)
A. Purpose These guidelines are intended to reduce the number of manufacturing changes that require preapproval by the FDA. The guidelines are published by the FDA. B. Function These guidelines provide recommendations to sponsors of NDAs, AADAs, and ANDAs during the postapproval period when: C. The FDA must be notified about a proposed change to…